Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Acute Lung Injury Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Acute Lung Injury Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Pharmacotherapy
      • 1.3.3 Mechanical Ventilation
      • 1.3.4 Adjunctive Procedures
      • 1.3.5 Fluid Management
      • 1.3.6 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Acute Lung Injury Market Share by Application (2019-2025)
      • 1.4.2 Hospitals
      • 1.4.3 Clinics
      • 1.4.4 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Acute Lung Injury Production Value 2014-2025
      • 2.1.2 Global Acute Lung Injury Production 2014-2025
      • 2.1.3 Global Acute Lung Injury Capacity 2014-2025
      • 2.1.4 Global Acute Lung Injury Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Acute Lung Injury Market Size CAGR of Key Regions
      • 2.2.2 Global Acute Lung Injury Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Acute Lung Injury Capacity by Manufacturers
      • 3.1.2 Global Acute Lung Injury Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Acute Lung Injury Revenue by Manufacturers (2014-2019)
      • 3.2.2 Acute Lung Injury Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Acute Lung Injury Market Concentration Ratio (CR5 and HHI)
    • 3.3 Acute Lung Injury Price by Manufacturers
    • 3.4 Key Manufacturers Acute Lung Injury Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Acute Lung Injury Market
    • 3.6 Key Manufacturers Acute Lung Injury Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Pharmacotherapy Production and Production Value (2014-2019)
      • 4.1.2 Mechanical Ventilation Production and Production Value (2014-2019)
      • 4.1.3 Adjunctive Procedures Production and Production Value (2014-2019)
      • 4.1.4 Fluid Management Production and Production Value (2014-2019)
      • 4.1.5 Others Production and Production Value (2014-2019)
    • 4.2 Global Acute Lung Injury Production Market Share by Type
    • 4.3 Global Acute Lung Injury Production Value Market Share by Type
    • 4.4 Acute Lung Injury Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Acute Lung Injury Consumption by Application

    6 Production by Regions

    • 6.1 Global Acute Lung Injury Production (History Data) by Regions 2014-2019
    • 6.2 Global Acute Lung Injury Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Acute Lung Injury Production Growth Rate 2014-2019
      • 6.3.2 United States Acute Lung Injury Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Acute Lung Injury Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Acute Lung Injury Production Growth Rate 2014-2019
      • 6.4.2 European Union Acute Lung Injury Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Acute Lung Injury Import & Export
    • 6.5 China
      • 6.5.1 China Acute Lung Injury Production Growth Rate 2014-2019
      • 6.5.2 China Acute Lung Injury Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Acute Lung Injury Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Acute Lung Injury Consumption by Regions

    • 7.1 Global Acute Lung Injury Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Acute Lung Injury Consumption by Type
      • 7.2.2 United States Acute Lung Injury Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Acute Lung Injury Consumption by Type
      • 7.3.2 European Union Acute Lung Injury Consumption by Application
    • 7.4 China
      • 7.4.1 China Acute Lung Injury Consumption by Type
      • 7.4.2 China Acute Lung Injury Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Acute Lung Injury Consumption by Type
      • 7.5.2 Rest of World Acute Lung Injury Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Altor BioScience
      • 8.1.1 Altor BioScience Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Acute Lung Injury
      • 8.1.4 Acute Lung Injury Product Introduction
      • 8.1.5 Altor BioScience Recent Development
    • 8.2 FirstString Research
      • 8.2.1 FirstString Research Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Acute Lung Injury
      • 8.2.4 Acute Lung Injury Product Introduction
      • 8.2.5 FirstString Research Recent Development
    • 8.3 GlaxoSmithKline
      • 8.3.1 GlaxoSmithKline Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Acute Lung Injury
      • 8.3.4 Acute Lung Injury Product Introduction
      • 8.3.5 GlaxoSmithKline Recent Development
    • 8.4 Forschung und Entwicklung
      • 8.4.1 Forschung und Entwicklung Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Acute Lung Injury
      • 8.4.4 Acute Lung Injury Product Introduction
      • 8.4.5 Forschung und Entwicklung Recent Development
    • 8.5 Commence Bio
      • 8.5.1 Commence Bio Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Acute Lung Injury
      • 8.5.4 Acute Lung Injury Product Introduction
      • 8.5.5 Commence Bio Recent Development
    • 8.6 CompleGen
      • 8.6.1 CompleGen Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Acute Lung Injury
      • 8.6.4 Acute Lung Injury Product Introduction
      • 8.6.5 CompleGen Recent Development
    • 8.7 Histocell S.L.
      • 8.7.1 Histocell S.L. Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Acute Lung Injury
      • 8.7.4 Acute Lung Injury Product Introduction
      • 8.7.5 Histocell S.L. Recent Development
    • 8.8 Stemedica Cell Technologies
      • 8.8.1 Stemedica Cell Technologies Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Acute Lung Injury
      • 8.8.4 Acute Lung Injury Product Introduction
      • 8.8.5 Stemedica Cell Technologies Recent Development
    • 8.9 Windtree Therapeutics
      • 8.9.1 Windtree Therapeutics Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Acute Lung Injury
      • 8.9.4 Acute Lung Injury Product Introduction
      • 8.9.5 Windtree Therapeutics Recent Development
    • 8.10 S-Evans Biosciences
      • 8.10.1 S-Evans Biosciences Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Acute Lung Injury
      • 8.10.4 Acute Lung Injury Product Introduction
      • 8.10.5 S-Evans Biosciences Recent Development

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Acute Lung Injury Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Acute Lung Injury Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Acute Lung Injury Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Acute Lung Injury Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Acute Lung Injury Production Forecast by Type
      • 9.7.2 Global Acute Lung Injury Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Acute Lung Injury Sales Channels
      • 10.2.2 Acute Lung Injury Distributors
    • 10.3 Acute Lung Injury Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Acute lung injury is a life-threatening condition caused by severe acute hypoxemic respiratory failure. It is a key source of mortality and morbidity in critically ill patients without any evidence of hydrostatic pulmonary edema.
      This kind of injury has a substantial impact on public health, with a high incidence across the world and it requires administration of a fast and goal-oriented therapy to suppress further lung damage.
      Symptoms observed in acute lung injury include severe shortness of breath, low blood pressure, confusion, and extreme tiredness. 
      In 2019, the market size of Acute Lung Injury is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Acute Lung Injury.

      This report studies the global market size of Acute Lung Injury, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Acute Lung Injury production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Altor BioScience
      FirstString Research
      GlaxoSmithKline
      Forschung und Entwicklung
      Commence Bio
      CompleGen
      Histocell S.L.
      Stemedica Cell Technologies
      Windtree Therapeutics
      S-Evans Biosciences

      Market Segment by Product Type
      Pharmacotherapy
      Mechanical Ventilation
      Adjunctive Procedures
      Fluid Management
      Others

      Market Segment by Application
      Hospitals
      Clinics
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Acute Lung Injury status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Acute Lung Injury manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Acute Lung Injury are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now